Targeting MDA-9/syntenin-1 (SDCBP) as a strategy to eliminate head and neck squamous cell carcinoma stem cells.
- DOI
- 10.1016/j.canlet.2026.218692
- Published
- 2026 Oct 1
- Container
- Cancer letters
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.canlet.2026.218692,
title = {Targeting MDA-9/syntenin-1 (SDCBP) as a strategy to eliminate head and neck squamous cell carcinoma stem cells.},
author = {Rilee GJ and Zaman SU and Manupati K and Ma Z and Hoyle RG and Bacolod MD and Lopresti MQ and Brown AM and Das SK and Fisher PB and Li J},
year = {2026},
journal = {Cancer letters},
doi = {10.1016/j.canlet.2026.218692},
url = {https://doi.org/10.1016/j.canlet.2026.218692}
}RIS
TY - JOUR TI - Targeting MDA-9/syntenin-1 (SDCBP) as a strategy to eliminate head and neck squamous cell carcinoma stem cells. AU - Rilee GJ AU - Zaman SU AU - Manupati K AU - Ma Z AU - Hoyle RG AU - Bacolod MD AU - Lopresti MQ AU - Brown AM AU - Das SK AU - Fisher PB AU - Li J PY - 2026 JO - Cancer letters DO - 10.1016/j.canlet.2026.218692 UR - https://doi.org/10.1016/j.canlet.2026.218692 ER -
APA
GJ, R., SU, Z., K, M., Z, M., RG, H., MD, B., MQ, L., AM, B., SK, D., PB, F., & J, L. (2026). Targeting MDA-9/syntenin-1 (SDCBP) as a strategy to eliminate head and neck squamous cell carcinoma stem cells.. Cancer letters. https://doi.org/10.1016/j.canlet.2026.218692
Source records
- pubmed · retrieved 2026-09-25T15:40:36.628Z